Swedish Biotech Cereno Raises SEK 60 M in Premium, Targeted Share Issue
Discover how Cereno Scientific raised SEK 60 million at a premium, fueling its next R&D phase while keeping shareholder value intact – a smart move in a buoyant Stockholm market.
3 minutes to read